Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy

Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy

Abstract Anticoagulation therapy has undergone significant evolution, marked by the emergence of direct oral anticoagulants with distinct advantages. Despite these advancements, challenges persist in managing residual thrombotic and bleeding risks, particularly among vulnerable populations. The purs...

Full description

Bibliographic Details
Main Authors: João Presume, Jorge Ferreira, Regina Ribeiras
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-02-01
Series:Cardiology and Therapy
Subjects:
Anticoagulants
Factor XI
Hemorrhage
Venous thromboembolism
Atrial fibrillation
Stroke
Online Access:https://doi.org/10.1007/s40119-024-00352-x

Internet

https://doi.org/10.1007/s40119-024-00352-x

Similar Items